Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

Clinical trial NCT01689558 · UNKNOWN

Trial details

NCT number: NCT01689558
Sponsor: Jin Feng
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

1、Enough Cases 2、Elekta Precise 1343 Digital Control Electron Linear Accelerator Can Undertake Nasopharyngeal Carcinoma Specimens in the Materia，Image Department of Nose Pharynx Ministry MRI Dynamic Testing,

Start date: 2011-12-01
Primary completion: 2015-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.